EVAX - CIK 0001828253
The table below shows Evaxion Biotech A/S's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $22.45M | $15.23M | $16.75M | $34.00M | $41.08M | $24.12M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $16.22M | $13.98M | $14.22M | $13.85M | $14.69M | $7.47M |
| Retained earnings | - | - | - | - | - | - |
| Total equity | - | - | - | - | - | - |